Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.
Gentronix has raised €1.7M across 2 funding rounds from 2 investors, most recently a round in Nov 2021. Based in Manchester, UK; founded 1999; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-11-15 | Other | €822k | Mercia’s Northern Venture Capital Trust (VCT) | View deal → |
| 2020-01-20 | Other | €881k | Mercia Asset Management | View deal → |
